Therapy Brands AI Products, Explained: What It Does and Who Owns It Now

The short answer: software for therapists, not an AI therapist

Therapy Brands AI products support clinical documentation and practice operations within the company now called Ensora Health. Therapy Brands is a business-to-business healthcare software firm. It sells the systems that therapy practices run on: scheduling, electronic health records, billing, telehealth, and claims. Its rebrand on April 7, 2025 explains why searches and practice paperwork may use either company name.

Its AI products point at paperwork. The flagship is an AI documentation assistant that listens to a therapy session and drafts the clinical note so the therapist edits instead of typing from scratch. The company has also announced AI for drafting treatment plans and for revenue cycle management, the industry term for billing and insurance claims.

None of this is client-facing AI support, and none of it is an AI acting as a therapist. The AI applications in therapy and counseling that practice software delivers sit firmly on the administrative side. But if your therapist's practice runs on these systems, the AI still touches you, because your sessions and records are the raw material. That is what the rest of this page unpacks.

What Therapy Brands is and who owns it

Therapy Brands built its business by rolling up practice-management software for therapy niches. Its portfolio has included TheraNest for mental and behavioral health, Fusion Web Clinic for pediatric and rehab therapy, plus ShareNote, CodeMetro, AccuPoint, DataFinch, TenEleven, Procentive, and A2C, covering everything from ABA data collection to substance use recovery clinics. By 2021 its tools supported more than 28,000 practices across the United States.

Ownership sits with private equity. On April 7, 2021, global investment firm KKR agreed to acquire a majority stake in Therapy Brands from investors including Lightyear Capital, Oak HC/FT, and Greater Sum Ventures, with PSG staying on as a minority shareholder. The deal closed on May 18, 2021. Independent coverage of therapist-software ownership has flagged this consolidation trend: a handful of investor-backed companies now own much of the records, billing, and data infrastructure of behavioral health care.

On April 7, 2025, the company rebranded as Ensora Health, and TheraNest became Ensora Mental Health. By its own announcement the company serves more than 200,000 individual providers across over 28,000 practices. For searchers, the practical takeaway is that Therapy Brands, Ensora Health, TheraNest, and Ensora Mental Health are the same corporate family.

The AI products that have actually shipped

The concrete product is the AI Session Assistant, built into TheraNest (Ensora Mental Health) and Fusion. It generates a draft clinical note from a session, structured in formats like SOAP, and the therapist reviews and edits the draft before it becomes part of the record. Independent reviews of the platform describe the tool as producing structured notes that require therapist review before finalization, with the vendor claiming large reductions in documentation time.

Coverage of the tool describes an arc from telehealth-only, where a recorded video session is transcribed and summarized, to in-person sessions using ambient listening. A July 14, 2026 announcement about the Fusion platform describes the AI Session Assistant, introduced earlier in 2026 on that product line, generating documentation during visits through ambient listening and dictation.

Beyond notes, the company's announced AI roadmap at the time of the 2025 rebrand included therapy note creation and enhancement, automatically generated treatment plans, and revenue cycle management intelligence, plus a plug-and-play framework for third-party AI partners to embed their products into the Ensora platform. Billing automation, claims scrubbing, and eligibility checks are the least visible pieces to clients but the most economically important to practices.

What has not shipped, and is not on the announced roadmap, is any consumer chatbot. If you want AI support for your own mental health between appointments, that is a separate category of tools with its own tradeoffs.

For searches about Therapy Brands machine learning applications, separate the feature from the underlying technology. Ask a sales representative which functions generate text, which apply billing rules, and which require a clinician to approve an output. A scheduling reminder or eligibility check alone does not establish that a product uses machine learning. Request a demonstration using fictional records before sharing any client information.

What this means if your therapist uses these systems

You will probably never see the software's name, but you may feel its effects in three places.

First, recording and listening. For an AI to draft a note from your session, the session has to be captured, either as a telehealth recording or through ambient listening in the room. That should never happen without your knowledge. In most states recording a conversation requires at least one party's consent, and responsible clinical use means explicit client consent, documented, before any session audio reaches an AI pipeline.

Second, AI-drafted notes. Your clinical record may now start life as a machine-written draft. The safeguard is human review: the therapist is responsible for reading, correcting, and signing the note. A rushed clinician who rubber-stamps drafts is the failure mode to care about, because notes feed diagnosis codes, insurance claims, and any future release of records.

Third, data flow. Session audio and transcripts are among the most sensitive data that exist about you. Vendor materials for these tools describe HIPAA compliance, business associate agreements, and short retention windows for recordings, and reviewers note the drafts stay inside the client chart. Those are the right design choices, but the details live in each practice's contracts and settings, which is why the questions in the next section are worth asking out loud.

There is also an upside worth naming. Every hour a clinician does not spend typing notes is an hour of attention that can go to clients, and a therapist who is present in session instead of half-documenting it is a better therapist for you. The point of scrutiny is to keep that trade honest, with consent and review intact, rather than to reject the tools outright.

Questions worth asking your therapist

You do not need to audit anyone. A few plain questions cover the ground, and a good practice will have ready answers.

Ask whether sessions are recorded or transcribed, and for what purpose. Ask whether an AI tool drafts the session notes, and whether you can see your notes on request, which is generally your right under HIPAA. Ask how long recordings or transcripts are kept and whether you can opt out of AI-assisted documentation while staying in care. Ask whether your data is used to train AI models; vendors in this space increasingly promise it is not, and it is fair to expect the practice to know the answer.

Asking these signals nothing negative about your therapist. Documentation load is a real driver of clinician burnout, and AI drafting is one of the more defensible uses of AI in mental health care precisely because a licensed human stays responsible for the record. The AI therapy privacy questions are the same ones you would ask of any app that touches your mental health data, just pointed at the office instead of your phone.

If a practice cannot tell you whether sessions are recorded or who reviews the notes, that is a real signal, and you are entitled to press or to decline consent.

HHS distinguishes ordinary clinical case notes, including SOAP notes, from separately maintained psychotherapy notes. The HIPAA access right generally covers the former, with limited exceptions; it excludes the latter. Ask the practice which record an AI draft becomes part of and how to request access or correction. Calling everything a therapy note can obscure this distinction.

How Therapy Brands operates: a cloud SaaS platform, not a single app

Therapy Brands, now Ensora Health, runs as a business-to-business software-as-a-service company. Practices do not buy and install the software once; they pay an ongoing subscription for cloud-based access, and the company describes its unified platform as offering cloud-based access across modern devices and browsers rather than software tied to one office computer.

That unified platform launched on May 5, 2025 at the National Council for Mental Wellbeing conference in Philadelphia, bringing the Ensora Mental Health (formerly TheraNest) and Fusion product lines together into one system. The stated goal was a single secure environment that can be configured to any size and type of practice, from a solo therapist to a multi-location group.

Its target audience is licensed providers, not the general public: therapists, counselors, psychologists, and social workers in mental and behavioral health, alongside physical therapists, occupational therapists, and speech-language pathologists in rehab settings, plus ABA and substance use recovery clinics. That is what searches for automated B2B solutions for psychologists are pointing at: subscription software that automates scheduling, documentation, and billing for the practice, scaled from individual providers up to enterprise organizations, rather than a product a client signs up for directly.

Corporate headquarters sit in Birmingham, Alabama. Combined with the ownership details above, the fuller picture is a Birmingham-based SaaS company, majority-owned by KKR with PSG as a minority shareholder, selling subscription access to a cloud platform used by more than 200,000 providers across over 28,000 practices.

For a purchasing decision, ask for a written quote that separates the core subscription, AI documentation, payment processing, billing services, onboarding, and record export. Ensora describes its operating model as product suites with add-ons and workflow services. Ask whether a feature is included in the proposed contract and available in the specific product your practice will use; a company-wide announcement does not establish that every account has access.

The bigger picture: admin AI is the quiet half of AI in therapy

Debates about AI and therapy usually orbit chatbots: whether talking to one helps, whether it is safe, whether it will ever replace clinicians. Meanwhile the adoption actually happening inside therapy practices looks like Therapy Brands' product line: notes, scheduling, claims, and compliance. This is the version of AI most likely to touch your care first, and it is also the version regulators have largely left alone, since laws like the Illinois AI therapy ban restrict AI from acting as the therapist while explicitly leaving room for AI that supports a licensed professional's admin work.

That regulatory line is worth internalizing as a consumer. AI that drafts a note under a licensed clinician's review sits on the permitted, lower-risk side. AI that presents itself as your counselor sits on the restricted side, and for good reasons of accountability and crisis capacity.

The through line is the one this hub keeps returning to: AI is useful where it removes friction around care, whether that is helping you find a therapist or sparing your therapist an hour of typing. The care itself stays human, accountable, and licensed. A company like Ensora Health betting its AI roadmap on paperwork rather than personas is, in its own way, evidence that the industry knows where that line is.